-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test is an affordable, accessible blood test that detects cancer in dogs.

Webinar Series: NETosis Induction in Isolated Neutrophils
- Share
- Tweet
- Share on Facebook
- Share
This video explains neutrophil extracellular traps (NETs) and their stimulation using PMA, a synthetic molecule. Dr. Andrew Retter breaks down a study where researchers observed the formation of NETs, indicated by DNA release correlating with H3.1, a key histone marker. The study divided the NET formation process into two phases: the first two hours, where nuclear decondensation occurs, and the period afterward, when DNA is expelled.

Click here for the next video in our series: Pneumococcus: an example of how bacteria can manipulate NETs to their advantage
Related Articles
- Share
- Tweet
- Share on Facebook
- Share
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields